Senators seek to retool drug agency's advertising efforts
- By Louis Jacobson
- November 24, 2003
- Comments
The bill would also end the public-relations and Web-related activities of the White House Office of National Drug Control Policy, and would direct the office to spend 89 percent of its federal appropriation on placing ads.
Shortly before the Hatch-Grassley-Biden bill was introduced, a House-Senate conference committee voted to require that 78 percent of the anti-drug program's $145 million budget be spent on advertising, according to AdAge.com.
Earlier tensions over Ogilvy's contract with the White House office led to an investigation by the General Accounting Office into charges of overbilling by the ad agency. As a result of the investigation, Ogilvy agreed to forgo $1.8 million in federal payments.
However, Ogilvy managed to win a contract renewal, thus irritating the sponsors of the Senate bill and other lawmakers.
Also, the media director for the White House drug-control office, Alan Levitt, quit this fall after feuding with both drug czar John Walters and the Partnership for a Drug-Free America.
Buyout Watch: Who's Offering What
Gimme My Discount! Deals for Feds
Retirements Rise
Insufficient Insourcing Data?
Holidays Aren't Enough to Help USPS
Government's Moneyball Moment
